Astro-Med, Inc. 10-Q Summary
Business Context and Reporting Period
This is a Quarterly Report (Form 10-Q) for Astro-Med, Inc., covering the three-month period ended May 1, 1999. The company operates in the data acquisition, digital color printing, and neurophysiology markets through its Test & Measurement, QuickLabel Systems (QLS), and Grass product lines.
Key Financial Metrics
| Metric | Q1 1999 | Q1 1998 |
|---|---|---|
| Net Sales | $10,377,257 | $10,056,440 |
| Gross Profit | $4,054,747 | $3,875,607 |
| Gross Margin | 39% | 39% |
| Operating Loss | $(514,312) | $(389,992) |
| Net Loss | $(270,529) | $(103,808) |
| Loss Per Share (Basic/Diluted) | $(0.06) | $(0.02) |
| Cash and Equivalents | $3,673,244 | $5,504,771 (End of Q1 1998) |
| Operating Cash Flow | $(508,778) | $358,042 |
| Current Ratio | 5.0 to 1 | N/A |
| Long-Term Debt | $0 | $16,977 |
Material Changes vs. Prior Period
- Revenue Mix Shift: Net sales increased 3% year-over-year. This growth was driven by a 42% increase in export sales, which offset a 7% decline in domestic channel sales. Specifically, the Test & Measurement line fell 24%, while QLS sales rose 24% and Grass sales rose 26%.
- Expense Growth: Operating expenses increased 7% to $4.57 million due to additions in sales personnel, sales incentives, R&D staff, and IT expenditures.
- Profitability Decline: Net loss widened from $104,000 to $271,000. This was exacerbated by a decrease in other income (from $249,000 to $153,000) due to unfavorable foreign currency translation adjustments and lower investment income.
- Liquidity: Cash and cash equivalents decreased by approximately $1.27 million during the quarter. Operating activities used $509,000 in cash, compared to providing $358,000 in the prior year.
Outlook, Risks, and Management Commentary
- Cost Reduction: Due to softness in traditional Test & Measurement markets, the company initiated a reduction in force at the start of the second quarter. Management expects to record approximately $200,000 in severance pay in Q2, which will lower the annualized break-even point by approximately $2 million.
- Capital Allocation: The company continued its share repurchase program, buying 18,500 shares for $96,000. Dividends of $0.04 per share were maintained.
- Year 2000 (Y2K) Readiness: The company estimates total Y2K compliance costs at $723,000, with $640,000 already expended. The IT infrastructure is 100% compliant; applications software is 50% complete. Management believes the total cost is not material to financial position but notes risks regarding third-party supplier compliance.
- Risks: Key risks include general economic conditions, competitive pricing pressures, inventory risks due to market demand shifts, and potential disruptions from Y2K issues affecting suppliers or customers.
Investor Verification Checklist
- Verify the impact of the Q2 personnel reduction on operating expenses and the projected $2 million annualized savings.
- Monitor the continued decline in the Test & Measurement product line versus the growth in QLS and Grass lines.
- Review the status of Year 2000 compliance for critical third-party suppliers and customers as evaluations are completed by mid-1999.
- Assess the sustainability of the dividend ($0.04/share) given the widening net loss and negative operating cash flow.
- Confirm the timeline for completing the remaining 50% of the Applications Software and Non-IT Y2K remediation.